These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Further insight into the dual COX-2 and 15-LOX anti-inflammatory activity of 1,3,4-thiadiazole-thiazolidinone hybrids: The contribution of the substituents at 5th positions is size dependent. Omar YM; Abdel-Moty SG; Abdu-Allah HHM Bioorg Chem; 2020 Apr; 97():103657. PubMed ID: 32086052 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 2-trifluoromethyl/sulfonamido-5,6-diaryl substituted imidazo[2,1-b]-1,3,4-thiadiazoles: a novel class of cyclooxygenase-2 inhibitors. Gadad AK; Palkar MB; Anand K; Noolvi MN; Boreddy TS; Wagwade J Bioorg Med Chem; 2008 Jan; 16(1):276-83. PubMed ID: 17937989 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile. Abdelazeem AH; El-Saadi MT; Safi El-Din AG; Omar HA; El-Moghazy SM Bioorg Med Chem; 2017 Jan; 25(2):665-676. PubMed ID: 27916468 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, molecular docking, and pharmacological evaluation of N-(2-(3,5-dimethoxyphenyl)benzoxazole-5-yl)benzamide derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Kaur A; Pathak DP; Sharma V; Wakode S Arch Pharm (Weinheim); 2018 Jun; 351(6):e1800008. PubMed ID: 29741797 [TBL] [Abstract][Full Text] [Related]
16. New 1,3,4-thiadiazole derivatives endowed with analgesic and anti-inflammatory activities. Schenone S; Brullo C; Bruno O; Bondavalli F; Ranise A; Filippelli W; Rinaldi B; Capuano A; Falcone G Bioorg Med Chem; 2006 Mar; 14(6):1698-705. PubMed ID: 16310359 [TBL] [Abstract][Full Text] [Related]
17. Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes. Maghraby MT; Abou-Ghadir OMF; Abdel-Moty SG; Ali AY; Salem OIA Bioorg Med Chem; 2020 Apr; 28(7):115403. PubMed ID: 32127262 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors. Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282 [TBL] [Abstract][Full Text] [Related]
19. A novel COX-2 inhibitor pyrazole derivative proven effective as an anti-inflammatory and analgesic drug. Mohy El-Din MM; Senbel AM; Bistawroos AA; El-Mallah A; Nour El-Din NA; Bekhit AA; Abd El Razik HA Basic Clin Pharmacol Toxicol; 2011 Apr; 108(4):263-73. PubMed ID: 21138530 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of phenyl quinoline phenol derivatives as COX-2 inhibitors; an approach to emergent the small molecules as the anti-inflammatory and analgesic therapeutics. Manikandan A; Ravichandran S; Sathiyanarayanan KI; Sivakumar A Inflammopharmacology; 2017 Dec; 25(6):621-631. PubMed ID: 28378280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]